📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CASI Pharmaceuticals

1.1 - Company Overview

CASI Pharmaceuticals Logo

CASI Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of business development aimed at building a pipeline through mutually beneficial transactions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CASI Pharmaceuticals

Rakuten Medical Logo

Rakuten Medical

HQ: United States Website
  • Description: Provider of investigational cancer therapies based on the proprietary Alluminox photoimmunotherapy platform, which combines a drug with targeting moieties and a light-activating device using non-thermal illumination to selectively target cancer cells; includes ASP-1929, an Alluminox-developed drug with dye-conjugated targeting moieties, approved in Japan for treating certain cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rakuten Medical company profile →
CoRegen Logo

CoRegen

HQ: United States Website
  • Description: Provider of SRC-3 and Treg-focused therapies: SRC-3 KO Treg Therapy that engineers Treg cells to infiltrate and destroy tumors; an SRC-3 small molecule inhibitor that blocks transcriptional activity to inhibit cancer growth and boost immune response; an SRC-3 small molecule enhancer to reduce inflammation and improve tissue repair in myocardial infarction and stroke; and Treg engineering.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CoRegen company profile →
BioImagene Logo

BioImagene

HQ: United States Website
  • Description: Provider of digital pathology solutions for clinical diagnostics and drug discovery, delivering integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories, including IHC algorithms such as HER2, ER/PR, and p53.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioImagene company profile →
Tilos Therapeutics Logo

Tilos Therapeutics

HQ: United States Website
  • Description: Provider of antibody therapeutics targeting key immunological pathways, with a focus on regulatory T cells and effector cell regulation; developing anti-LAP antibodies specific to the Latency Associated Peptide of TGF beta for cancer treatment. Founded in 2016 and based in Cambridge, Massachusetts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tilos Therapeutics company profile →
Mirati Therapeutics Logo

Mirati Therapeutics

HQ: Canada Website
  • Description: Provider of novel cancer therapeutics in clinical development and commercialization; product candidates include MGCD265, an oral, multi-targeted kinase inhibitor targeting the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mirati Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CASI Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CASI Pharmaceuticals

2.2 - Growth funds investing in similar companies to CASI Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CASI Pharmaceuticals

4.2 - Public trading comparable groups for CASI Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CASI Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CASI Pharmaceuticals

What does CASI Pharmaceuticals do?

CASI Pharmaceuticals is a provider of business development aimed at building a pipeline through mutually beneficial transactions.

Who are CASI Pharmaceuticals's competitors?

CASI Pharmaceuticals's competitors and similar companies include Rakuten Medical, CoRegen, BioImagene, Tilos Therapeutics, and Mirati Therapeutics.

Where is CASI Pharmaceuticals headquartered?

CASI Pharmaceuticals is headquartered in United States.

How many employees does CASI Pharmaceuticals have?

CASI Pharmaceuticals has 1,000 employees 🔒.

When was CASI Pharmaceuticals founded?

CASI Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is CASI Pharmaceuticals in?

CASI Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CASI Pharmaceuticals

Who are the top strategic acquirers in CASI Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in CASI Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CASI Pharmaceuticals?

Top strategic M&A buyers groups and sectors for CASI Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CASI Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in CASI Pharmaceuticals's sector and industry vertical?

Top PE firms investing in CASI Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CASI Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CASI Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CASI Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CASI Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CASI Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CASI Pharmaceuticals?

The key public trading comparables and valuation benchmarks for CASI Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CASI Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CASI Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CASI Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CASI Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CASI Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in CASI Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CASI Pharmaceuticals

Launch login modal Launch register modal